Currently Enrolling

The iVAS Feasibility Trial is currently enrolling. If you are interested in learning more or to see if you qualify, please visit clinicaltrials.gov.

The Procedure

Designed to be minimally invasive and replaceable, iVAS is currently implanted in the operating room and will eventually be implanted in a hybrid operating room suite or catheterization lab.

The iVAS Device

iVAS is the first minimally invasive, long-term, ambulatory counterpulsation device that works in sync with the heart.

Caution- Investigational Device, Limited by United States Law to Investigational Use
Not Available for Sale.